Delivery Order SPE2DX22D0019-SPE2D826FCS90

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $16,067.10 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on January 27, 2026, with an ultimate completion date of January 28, 2026. This non-set-aside competitive award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order falls within AmerisourceBergen's established role as a critical vendor supplying pharmaceutical products and medical supplies to military and federal healthcare systems.

AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly operating under the AmerisourceBergen name), which serves as the parent organization and holds the primary $999,999,999.00 IDC with DLA through December 31, 2031. The broader contract vehicle enables the company to deliver a comprehensive range of pharmaceutical commodities, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains to support military healthcare programs globally. DLA Troop Support is planning to establish a new Pharmaceutical Prime Vendor Global Program Generation V contract structure with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.